Booster Dose Won't Necessarily Protect From Omicron: Government Sources

Posted by harsh sultayia on December 15th, 2021

New Delhi A third cure of a Covid vaccine- recommended by several foreign countries and medical experts-won\'t inescapably cover you from the Omicron variant, Union Health Ministry sources told NDTV Tuesday, amid hesitancy by the government to authorise supporter shots for Indian citizens. 

 Health Ministry sources refocused to Omicron cases in Israel, the United States and other countries to cast mistrustfulness over the extent to which a third vaccine cure can guard against the contagion. 

 The government, still, has also told the Delhi High Court it\'s considering substantiation related to the need and defense of supporter boluses. 

 This comes on the heels of the WHO this week saying Omicron is more transmittable than Delta-which is responsible for utmost of the world\'s coronavirus infections, and over 60 per cent of all similar infections in India, according to the Health Ministry-and reduces vaccine efficacity. 

 Medical experts, while admitting, a supporter cure might not completely cover against the variant, it represents\"our stylish chance, with other public health measures, of keeping people out of hospitals\". 

 Junior Health Minister Dr Bharati Pravin Pawar has told Parliament 60 nations- including the US, Germany, Austria, Canada and France-are giving boosters. The UK has blazoned analogous plans. 

 Australia-one of the world\'s most vaccinated countries with over 90 per cent of all above 16 invested-has said it\'ll reduce the waiting time for supporter shots. 

 This week an original study in the UK-where Omicron cases are anticipated to\"dramatically increase\"- plant a third cure of the AstraZeneca or Pfizer-BioNTech dabs offered 70-75 per cent protection. 

 The UK has come the first country to report a death related to Omicron. 

 Pfizer-BioNTech has also said original lab studies show a third cure of their vaccine may be demanded to neutralize the Omicron variant. 

 The AstraZeneca vaccine is made and vended in India as Covishield by the Serum Institute. CEO Adar Poonawalla said last week said he\'d room to increase product, if demanded for supporter shots. 

 SII has applied to the government for clarity on a implicit supporter programme, but an expert panel of the Medicine Controller General of India has asked for\" defense\"for fresh shots. 

 The WHO has cited early data that indicates the Omicron strain- reported first in South Africa last month and now in over 70 countries-to advise that this variant could worsen the spread of the contagion. 

 The Omicron variant is reported to have 50 mutations that sparked fear among virologists, particularly since further than half are on the shaft protein-which is what being vaccines target. 

\"Boosters are indeed more critical,\"Gregory Poland, director of the US- grounded Mayo Clinic\'s Vaccine Research Group told Bloomberg this month,\"not only to elevate ( individual) impunity. but also population- position impunity (to guard against) emergence of new variants.\"

 India has 49 verified cases of the Omicron variant just 12 days after reporting its first. Health Ministry sources said 11, including an 18-month-old girl, have been discharged after treatment.